INTRODUCTION
Pharmacological, biochemical, and genetic manipulations both in invertebrates (such as Aplysia) and mammals, have provided convincing evidence that 5-hydroxytryptamine (5-HT, serotonin), one of the oldest signaling substances to appear during evolution Michael et al., 1998) , is involved in learning and memory (Kandel and Schwartz, 1982) . 5-HT also regulates neurogenesis, neurite outgrowth, dendritic spine densities, and long-term synapse reinforcement Gaspar et al., 2003; Banasr et al., 2004) . Among the 5-HT receptors (5-HTRs) involved in learning and memory, those coupled to G s , are particularly important, because cAMP emerges as a key player in memory events and associated synaptic plasticity events, such as long-term potentiation (LTP) (Siegelbaum and Kandel, 1991) . In mammals, the 5-HT 4 Rs-G s coupled receptors are important modulators of learning and memory Manahan-Vaughan, 2004, 2005) . Nothing is known about their action, in vivo, on another key signaling pathway involved in learning and memory: the extracellular signal-regulated kinase (ERK) pathway (Sweatt, 2004) . However, Rs have been demonstrated to activate the ERK pathway in human embryonic kidney 293 (HEK293) cells (Norum et al., 2003) . Our aim was to examine whether this activation also occurs in neurons. Indeed, we observed a 5-HT 4 R-induced activation of ERKs in neurons in primary culture, but the unexpected finding was that this activation was mostly a protein kinase A (PKA)-independent event.
There are many possible signaling pathways by which a G protein-coupled receptor (GPCR) can activate ERKs. They can be classified in two main pathways. The first pathway uses a classical G protein activation followed by transduction, via ␤␥ and/or kinases that depend on second messengers (such as PKA, PKC, and phosphatidylinositol 3-kinase [PI3K]), Ras or Rap exchange factors, and finally activation of receptor (epidermal growth factor-receptor [EGF-R]) or nonreceptor (Src) tyrosine kinases (Luttrell, 2005) . The second pathway does not require G proteins. Indeed, this pathway occurs after G protein uncoupling. ␤-Arrestins that participate in this uncoupling also mediate endocytosis of the receptor, via clathrin-coated pits. This change of compartment allows the ␤-arrestin scaffolding of a new signaling complex, where early signaling proteins, such as Src, are close to members of the ERK pathway, such as Raf and mitogen-activated protein kinase kinase (MEK) (Lefkowitz and Shenoy, 2005; Wang et al., 2006) . Interestingly, the time courses of the G-dependent and the ␤-arrestin-dependent activation of the ERK pathways are very different. The first activation is transient (a few minutes); the second activation is more persistent (up to 1 h) and depends on the duration of the receptor endocytosis, which is much longer for class B than for class A receptors (Oakley et al., 2001) .
The aim of this study was to explore the signaling events involved in ERK activation by 5-HT 4 R, because the PKA pathway, the major signaling cascade of 5-HT 4 R, is not implicated in neurons.
We report that 5-HT 4 R activates the ERK pathway independently of G protein cascades and ␤-arrestin but that it requires Src tyrosine kinase activation. This pattern of signaling events occurs as well in HEK cells as in neurons.
MATERIALS AND METHODS

Plasmids and Construction of Mutated 5-HT 4 R cDNAs
Plasmid pcDNA-3.1-␤-arrestin 2-YFP was generously provided by M. Bouvier (University of Montreal, Montreal, Quebec, Canada). Truncated receptor constructs are already described by Claeysen et al. (1999) . Briefly, constructs ⌬346 were obtained by inserting a stop codon after residues 346 in the 5-HT 4 R cDNA sequence, with the QuikChange site-directed mutagenesis kit (Stratagene, Amsterdam, The Netherlands). 5-HT 4 D66N and W272A were generated using the same protocol.
Antibodies
Anti-phospho PKA substrates, anti-p44/p42 mitogen-activated protein kinase (MAPK) (ERK1/2), anti-phospho-p44/p42 MAPK (Thr202/Tyr204), antiphospho-Src (Tyr 416), and anti-Src Pan are all polyclonal antibodies purchased from Cell Signaling Technology (Ozyme, France).
The mouse anti-Rho tag antibody was provided by Dr. S. Costagliola (Institut de Recherche en Biologie Humaine et Nucléaire, Brussels, Belgium) (Adamus et al., 1991) . The anti-␤-arrestin 1 A1CT was a gift from Dr. R. J. Lefkowitz (Duke University Medical Center, Durham, NC) . The anti-␤-arrestin 2 was purchased from Sigma-Aldrich (St. Louis, MO). Alexa Fluor 488-and Alexa 594-labeled secondary antibodies were purchased from Invitrogen (Cergy-Pontoise, France). The horseradish peroxidase-conjugated anti-rabbit and anti-mouse antibodies were from GE Healthcare (Orsay, France).
Small Interfering RNA (siRNA) Transfection
The double-stranded siRNA sequence 5Ј-ACCUGCGCCUUCCGCUAUG-3Ј was used to simultaneously target human ␤-arrestin 1 (positions [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] and ␤-arrestin 2 (positions [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] . Indicated position numbers are relative to the start codon. One small RNA duplex that has no silencing effect was used as a control (5Ј-AAGUGGACCCUGUAGAUGGCG-3Ј). All the siRNAs were chemically synthesized (Eurogentec, Seraing, Belgium), and they were described and validated previously (Gesty-Palmer et al., 2006; Kara et al., 2006) . Early passage HEK293 cells at 40% confluence were transfected into six-well plates with 300 ng of plasmid encoding the wt-5-HT 4 R. After cell adhesion, siRNAs were transfected at 200 nM by using the Gene Silencer transfection reagent according to the manufacturer's recommendations (Gene Therapy Systems, San Diego, CA). Briefly, 50 l of the Gene Silencer transfection reagent was added to 300 l of minimal essential medium (MEM), whereas RNA mixtures containing 36 l at 75 M Ϸ20 g of RNA, 240 l of siRNA diluent, and 180 l of MEM were prepared. Both solutions were allowed to stand 5-10 min at room temperature, and they were mixed by inversion. After a 10-to 20-min incubation at room temperature, the transfection mixture was divided into six equivalent fractions and added to cells into six-well plates containing 750 l of fresh, serum-free DMEM. After cells were incubated for 4 h at 37°C, an additional 1 ml of DMEM with 20% fetal calf serum (FCS) and 2% penicillin/streptomycin were added to the wells. All assays were performed 3 d after siRNA transfection.
Cell Cultures and Transfection
Primary cultures of colliculi neurons were prepared as described previously (Dumuis et al., 1988) . Briefly, cells dissociated from colliculi of 14-to 15-d-old Swiss mouse embryos were plated in serum-free medium in 12-well culture dishes (0.8 ϫ 10 6 cells/ml; 1 ml/dish). Cultures were maintained for 6 -8 d at 37°C in a humidified atmosphere in 5% CO 2 /95% H 2 O/air and in DMEM/ F-12 supplemented with 10% of mix hormone (100 g/ml transferrin, 25 g/ml insulin, 60 M putrescine, 20 nM progesterone, and 30 nM sodium selenite) and antibiotics. HEK293 cells were grown in DMEM supplemented with 10% of dialyzed FCS and antibiotics. Once at confluence, cells were transfected by electroporation, as previously described (Claeysen et al., 1999) . Colliculi neurons, as well as transfected HEK293 cells, were processed for subsequent experiments, such as immunofluorescence, immunoblotting, or measurement of second messengers (cAMP or inositol phosphates).
Phosphorylation Assays
Cells transfected with the indicated amount of plasmid were plated on six-well dishes and grown for 24 h in DMEM in 10% dialyzed fetal calf serum. Before stimulation, the cells were starved for at least 6 h in serum-free medium. After stimulation, cells were lysed in SDS buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% SDS, proteases inhibitors mixture, and phosphatases inhibitors [1 mM sodium orthovanadate, 10 mM sodium fluoride, and 10 mM pyrophosphate]). Cell lysates were incubated for 20 min at 4°C and subsequently centrifuged at 12,000 rpm for 10 min at 4°C. For each sample, the amount of proteins was determined by bicinchoninic acid method (SigmaAldrich). Four times concentrated Laemmli buffer was added to cell lysates, and proteins were separated by electrophoresis on a 10% SDS-polyacrylamide gel. The proteins were transferred to nitrocellulose membranes (Hybond-C; Amersham Biosciences) at 18 V until intensity of current stopped decreasing. Membrane were blocked for 1 h at room temperature using Tris-buffered saline blocking solution, containing 5% (wt/vol) milk powder, 0.25% (vol/ vol) Tween 20. Membranes were immunoblotted successively with the primary antibodies overnight at 4°C (either 1:1000 anti-p-PKA substrates, antip44/p42 (pERK1/2), total anti-p44/p42 (ERK1/2), anti-p-Src (Tyr416), or Src Pan rabbit polyclonal antibody), washed extensively, and incubated with secondary antibodies. After the detection of phosphorylated bands using a Chemiluminescence Reagent Plus kit (PerkinElmer-Cetus, Courtaboeuf, France) and autoradiography, the membranes were stripped with 100 mM glycine, pH 2.2, 0.2% SDS, and 0.1% NP-40 for 30 min at room temperature, rinsed with wash buffer, and immunoblotted as described above with another primary antibody. Autoradiographs were digitized and subsequent analyses were performed with ImageJ (National Institutes of Health, Bethesda, MD) and GraphPad Prism (GraphPad Software, San Diego, CA).
Determination of cAMP Production in Transfected Cells
HEK293 cells were transfected with the appropriate cDNA and seeded into 24-well plates (500,000 cells/well). Twenty-four hours after transfection, a 5-min-stimulation with the appropriate concentrations of 5-HT, 0.1 mM lascorbic acid, and 0.1 mM phosphodiesterase inhibitor Ro-20-1724 was performed at 37°C in 250 l of HBS (20 mM HEPES, 150 mM NaCl, 4.2 mM KCl, 0.9 mM CaCl 2 , 0.5 mM MgCl 2 , 0.1% glucose, and 0.1% bovine serum albumin [BSA] ). The same volume of Triton X-100 (0.1%) was added to stop the reaction, and then the cells were incubated 30 min at 37°C. Quantification of cAMP production was performed by homogenous time resolved fluorescence (HTRF) by using the cAMP Dynamic kit (CIS Biointernational, Bagnols-surCèze, France) according to the manufacturer's instructions.
Determination of Inositol Production in Transfected Cells
Cells are plated into 24-well dishes (700,000 cells/well). Twenty-four hours after transfection, 50 mM LiCl was added 10 min before a 30-min stimulation with the appropriate concentration of 5-HT and 0.1 mM l-ascorbic acid in HEPES buffer saline (HBS). Quantification of inositol phosphates (IP) production was performed by HTRF, using the IP-One assay (CIS Biointernational), according to the manufacturer's instructions.
Immunofluorescence Microscopy
HEK293 cells expressing tagged wild type (wt) or ⌬346-5-HT 4 -R with or without yellow fluorescent protein (YFP)-tagged ␤-arrestin 2 were grown on poly-l-ornithine-coated glass coverslips and incubated in DMEM with 10% fetal calf serum. Thirty-four hours after transfection, cells were serum-starved overnight. To visualize Rho-tagged receptors, cell surface receptors were labeled with 2 g/ml antibody for 90 min at 4°C. Cells were then washed with serum-free medium and stimulated with 10 M 5-HT in the same medium at 37°C. Cells were washed with phosphate-buffered saline, fixed with 4% paraformaldehyde for 20 min at room temperature, and then permeabilized with 0.05% Triton X-100. Cells were then incubated for 1 h at room temperature with goat anti-mouse antibody coupled to Alexa Fluor 488 or 594 at 2 g/ml with or without goat anti-rabbit antibody coupled to Alexa Fluor 594 at 2 g/ml. After extensive washes, the coverslips were mounted onto slides by using Mowiol mounting media (Hoechst, Frankfurt, Germany). Immunofluorescence microscopy was performed using a Zeiss Axiophot2 microscope (Carl Zeiss, Jena, Germany) 
Coimmunoprecipitation Experiments
HEK293 cells were transfected with wt or ⌬346 Rho-tagged 5-HT 4 R construct as indicated in the figure legends. Cells were seeded at 10 6 /150-mm plate 48 h before the experiment. Briefly, a 5-min stimulation with 10 Ϫ5 M 5-HT was performed at 37°C in DMEM without serum. Then, the cross-linking reaction was realized during 30 min in Locke's buffer completed with 1.25 mM of dithiobis(succinimidyl propionate) (Pierce Chemical, Perbio-Brebières, France) a membrane-permeable, hydrolysable covalent cross-linker. The cross-linking reaction was stopped with Locke 10% FCS. After two washes with Locke's buffer, cells were incubated in lysis/binding buffer (20 mM HEPES, 150 mM NaCl, 1% NP-40, 10% glycerol, 4 mg/ml dodecylmaltoside, 0.8 mg/ml cholesteryl hemisuccinate, phosphatase, and protease inhibitor). After 30 min of incubation at 4°C, the samples were centrifuged at 15,000 rpm for 15 min. The soluble extract was incubated overnight at 4°C with 20 l of a mixture 1:1 of protein A/protein G-Sepharose beads (Amersham Pharmacia Biotech) precoupled with 8 g of anti-Rho-tag antibody. After five washes with homogenization buffer, immunoprecipitated proteins were eluted in Laemmli sample buffer, resolved by SDS-polyacrylamide gel electrophoresis, and detected by Western blotting.
Data Analysis
The dose-response curves were fitted using GraphPad Prism, and the following equation for monophasic dose-response curves: y ϭ (y max Ϫ y min )/1 ϩ [(x/EC 50 ) n H ] ϩ y min , where EC 50 is the concentration of the compound necessary to obtain 50% of the maximal effect, and n H is the Hill coefficient. All data represented correspond to the mean Ϯ SEM of three independent experiments performed in triplicate. Statistical analysis was carried out with the t test using GraphPad Prism 3.0 software. p values Ͻ0.05 were considered as statistically significant.
RESULTS
Activation of ERK by the G s -coupled 5-HT 4 Rs in Neurons
Mostly Takes Place through a cAMP-independent Pathway In cultured colliculi neurons, endogenous 5-HT 4 Rs are coupled to the G s /cAMP pathway (Dumuis et al., 1988) . Indeed, a 2-to 15-min stimulation period with BIMU8 (a selective 5-HT 4 R agonist) ) generated a twofold activation of cAMP production ( Figure 1A ). BIMU8 also increased the level of p-ERK1/2, and this activation was transient ( Figure 1B) . Indeed, p-ERK reached a maximal signal after 5-min stimulation and decreased to the basal level after 15 min. This time course of ERK phosphorylation contrasted with those obtained with other GPCRs, such as ␤ 2 adrenergic receptors (␤ 2 -ARs), vasopressin V2 (V 2 Rs), or angiotensin II type 1a receptors (AT1AR) Ren et al., 2005; Shenoy et al., 2006) . In these latter cases, the ERK1/2 activation time courses were divided into two components, a transient G protein-dependent component and a persistent G protein-independent and ␤-arrestin-dependent component.
Because 5-HT 4 R-mediated activation of ERK1/2 was transient, we investigated whether this pathway was G protein signaling dependent. We first attempted to evaluate the contribution of the G s /cAMP/PKA pathway. To investigate the role of PKA in 5-HT 4 R-mediated ERK1/2 activation in colliculi neurons, we examined the amount of BIMU8-induced p-ERK1/2 in the presence and absence of 4-cyano-3-methylisoquinoline (CMIQ), a selective PKA inhibitor (He and Yeung, 2003) . Before this experiment, we determined the concentration of CMIQ necessary to inhibit PKA in neuronal cultures. Immunoblotting with an anti-phospho-PKA substrate revealed that pretreatment of neurons with a concentration of 3 M CMIQ was sufficient to completely inhibit for the same periods as mentioned in A, and then they were lysed. The phosphorylation state of ERK1/2 of whole cell extract was analyzed by immunoblotting with the antibody to p-ERK1/2. Membranes were then stripped and analyzed with antibody to total ERK. The Western blot shown is representative of five independent experiments. (C) Inhibition of PKA does not lead to the inhibition of p-ERK1/2 in colliculi neurons. Colliculi neurons expressing endogenous 5-HT 4 R were pretreated with vehicle or 3 M CMIQ for 30 min before treatment with 10 M BIMU8 for 5 min. Cell lysates were successively analyzed by immunoblotting with the antibodies to phospho-PKA substrates, to p-ERK1/2, and to total ERK as described in B. The Western blot shown is representative of three independent experiments. the 5-HT 4 R-induced activation of PKA ( Figure 1C ). We found that BIMU8 still generated ERK1/2 activation in the presence of 3 M CMIQ with only a slight decrease in p-ERK1/2 signal ( Figure 1C ).
Our results suggest that activation of 5-HT 4 Rs in neurons could induce activation of ERK through a pathway largely independent of PKA. In neurons, a G q -dependent ERK activation can also be excluded, because we detected no IP accumulation after activation of endogenous 5-HT 4 Rs (data not shown).
G Protein-independent ERK1/2 Activation by 5-HT 4 Rs in HEK293 Cells
In an effort to better understand the molecular mechanisms involved in 5-HT 4 R-mediated ERK phosphorylation, we used HEK293 cells transiently transfected with 5-HT 4 Rs. We chose HEK293 cells to take advantage of the genetic and molecular tools difficult to set up in primary cultured neurons, such as transfection of cDNA, as well as siRNA. As in colliculi neurons, the time course of 5-HT 4 R-induced p-ERK1/2 accumulation observed in HEK293 cells was very transient with a maximum effect after 5 min of stimulation, and the effect returned to the basal level after 10 -20 min of stimulation ( Figure 2A ). The concentration-response curve of the 5-HT 4 R ligand-mediated p-ERK1/2 indicated an EC 50 of 3 Ϯ 0.2 ϫ 10 Ϫ7 M ( Figures 2B and 3 ), a value much higher than the EC 50 determined for 5-HT 4 R-mediated cAMP accumulation in the same cells (0.9 Ϯ 0.1 ϫ 10 Ϫ9 M) ( Figure 3 ). We then attempted to evaluate how much ERK1/2 activation by 5-HT 4 R was dependent on G s , G q , or G i signaling cascades. First, note that in HEK293 cells, 5-HT 4 Rs were also able to stimulate IP accumulation with an EC 50 for 5-HT slightly higher than its EC 50 to stimulate p-ERK accumulation ( Figure 3 ). We generated several 5-HT 4 R mutants with different specificities of G protein pathway activation. When the highly conserved aspartate D66 (D 2.50 ) in the second transmembrane domain was replaced by an asparagine (N), the receptor was still able to stimulate cAMP production ( Figure 3 ). However, without losing its coupling to G s , this mutant was absolutely unable to stimulate p-ERK1/2 accumulation or stimulate IP accumulation ( Figure 3 ). This was the first initial evidence to prove that the G s /cAMP pathway was not involved in p-ERK1/2 accumulation after 5-HT 4 R activation. To exclude the involvement of the G q /inositol-1,4,5-triphosphate pathway, we used the W272A (W 6.48 ) mutant, which was completely unable to induce an increase in IP accumulation, but it was still able to increase ERK1/2 phosphorylation in response to 5-HT stimulation, although with a lower potency (EC 50 ϭ 30 Ϯ 4 ϫ 10 Ϫ7 M) and efficacy (78 Ϯ 6% of the WT) than the native receptor ( Figure 3) . It was also able to increase cAMP. Results with both mutants suggest that neither cAMP nor IP was involved in 5-HT 4 Rmediated ERK1/2 activation.
To further validate the absence of a role for the G s /cAMP pathway in 5-HT 4 Rs-mediated p-ERK1/2 accumulation in HEK293 cells, we examined the effect of 1 mM SQ 22536, an adenylyl cyclase inhibitor. This drug inhibited 5-HT 4 R-stimulated cAMP accumulation by Ͼ85% ( Figure 4B ). However, the accumulation of p-ERK1/2 in the presence of 5-HT remained unchanged ( Figure 4A ). Similarly to the experiment carried out in colliculi neurons, we determined the concentration of CMIQ necessary to inhibit PKA in HEK293 cells lines. We also tested H-89, another PKA inhibitor. Immunoblotting with an anti-phospho-PKA substrate revealed that pretreatment of HEK293 cells with either a concentration of 3 M CMIQ or 1 M H-89 was sufficient to completely inhibit the 5-HT 4 R-stimulated activation of PKA ( Figure   4C ). In parallel, we found that 5-HT still generated ERK1/2 activation in the presence of 3 M CMIQ or 1 M H-89. Furthermore, we observed that forskolin did not activate ERK1/2 in HEK293 cells (data not shown). This has also been reported by Rey et al. (2006) who concluded that in HEK cells, ERK activation is not responsive to direct stimulation of adenylyl cyclase with forskolin.
To confirm that 5-HT 4 R-stimulated ERK1/2 activity did not depend on the G q /IP/phospholipase C (PLC) pathway, we exposed the cells to a PLC inhibitor, U 73122 at 10 M, and to its inactive analogue U 73434 at 10 M. Neither of these inhibitors could suppress ERK1/2 activation ( Figure  5A) ; however, U 73122 inhibited ϳ75% of IP accumulation produced under 5-HT 4 R activation ( Figure 5B ). To independently assess the role of G i in the activation of ERK1/2, we also determined the effect of pertussis toxin (PTX) preincubation of HEK293 cells expressing the 5-HT 4 R. ␤ 2 -ARs can switch from a G s to a G i coupling and subsequently activate the ERK pathway via ␤␥. We observed no such event for 5-HT 4 Rs. Indeed, a PTX treatment of HEK293 cells had no effect on 5-HT 4 R-mediated accumulation of p-ERK1/2 (FigFigure 2 . Time course of agonist-stimulated ERK1/2 phosphorylation. (A) HEK293 cells were transfected with 100 ng of 5-HT 4 R. Twenty-four hours later, the cells were starved in serum-free medium overnight and stimulated with 10 M 5-HT for the indicated periods at 37°C. Phosphorylated (p-ERK1/2) and total ERK1/2 of the same cell lysate were determined by immunoblotting with the antibody to p-ERK1/2 or to total ERK. p-ERK1/2 bands were quantified by densitometry and normalized to ERK level and expressed as a percentage of the maximal p-ERK1/2 (obtained at 5 min). Data from four independent experiments are represented as the mean Ϯ SEM and plotted in the graph below. (B) HEK293 cells expressing the 5-HT 4 R were starved in serum-free medium overnight and stimulated with increasing concentrations of 5-HT (3 ϫ 10 Ϫ10 -3ϫ 10 Ϫ4 M). Representative blots of p-ERK1/2 and ERK are shown in A and B.
G. Barthet et al. ure 5C). Altogether, the present data indicate that 5-HTstimulated p-ERK accumulation in cells expressing 5-HT 4 R does not require the generation of a classical second messenger that is dependent on G protein (G s , G i , and G q ) signaling.
To exclude that ERK activation could perhaps result from the transactivation of EGF-R as described for some GPCRs in HEK293 cells (Turner et al., 2001; Beom et al., 2004) , we tested the effect of AG1478, a selective EGF-R inhibitor, on ERK1/2 activation in response to 5-HT. As shown in Figure 5D , 250 nM tyrphostin/AG1478 does not reduce ERK1/2 activation induced by 5-HT 4 R activation, whereas at this concentration EGF-R-mediated ERK activation was inhibited. Moreover, pretreating HEK293 cells with 100 nM wortmannin 30 min before activation of the 5-HT 4 R excludes the involvement of PI3 kinase in 5-HT 4 R-mediated activation of ERK1/2 (data not shown).
5-HT 4 R-induced ERK Phosphorylation Involves Src Kinase
Previous studies have demonstrated that activation of the 5-HT 4 Rs present in the enterocyte Caco-2 cell line inhibits apical Cl Ϫ /OH Ϫ exchange activity by activating the nonreceptor tyrosine kinase Src (Saksena et al., 2005) . Moreover, Src has been shown to play a prominent role in GPCRinduced ERK activation (Luttrell and Luttrell, 2004) . In a few situations, Src may directly be activated by binding to the GPCR, although a G protein was involved (␤ 3 -AR and P2Y2 receptors) (Cao et al., 2000; Liu et al., 2004) . Src can also be activated after its recruitment by ␤-arrestin together with members of the ERK cascade such as Raf and MEK during ␤-arrestin-dependent endocytosis of the receptor (Wang et al., 2006) . To determine whether one of these mechanisms was required for 5-HT 4 R-induced activation of ERK1/2, we first tested the sensitivity of this activation on the Src-specific tyrosine kinase inhibitor PP2 (Bain et al., 2003) . As illustrated in Figure 6A , line 1, pretreating the cells with 10 M PP2 resulted in a dramatic decrease (Ͼ 80%) in p-ERK accumulation. In contrast, 5-HT 4 R-dependent ERK1/2 phosphorylation was only slightly reduced by PP3, a structural analogue of PP2 that does not inhibit Src kinase. To further establish the role of Src, we demonstrated that phosphorylation of Src kinase at Tyr 416 was induced by 5-HT 4 Rs stimulation, an effect blocked by PP2 but not PP3 ( Figure 6A , line 2).
Data in Figure 6B show immunofluorescence detection of Rho-tagged 5-HT 4 Rs, p-ERK1/2 as well as p-Src (Tyr 416) in HEK293 cells under basal conditions or after stimulation with 10 M 5-HT for 5 and 30 min. Under basal conditions, a very low level of p-ERK1/2 was detected, whereas an intense accumulation of p-ERK1/2 was observed after 5-HT stimulation for 5 min. Note that there was a clear colocalization between the receptor and p-ERK1/2 at the submembrane level. p-Src was already detected under basal conditions and stimulation of 5-HT 4 Rs for 5 min with 5-HT, further increased p-Src levels. As illustrated in Figure 6B , a colocalization between 5-HT 4 Rs and p-Src at the plasma membrane level can be observed. As already described using immunoblotting experiments (Figure 2) , the immunofluorescence experiments in Figure 6 further confirmed that a 30-min stimulation with 5-HT was not associated with a persistent accumulation of p-ERK1/2. At 30 min, the receptors could still be detected at the cell surface and also in a perinuclear area, as described previously (Barthet et al., with 5-HT, in contrast to the activation of ERK1/2, was persistent up to 30 min ( Figure 6C ).
The 5-HT 4 R-induced Accumulation of p-ERK1/2 Is Not Dependent on ␤-Arrestin Recruitment
Recently, a very well documented concept proposed that GPCRs can trigger non-G protein-mediated signaling events. These events are generally mediated via the association of GPCRs with GPCR-associated proteins, such as ␤-arrestin. In particular, the activation of ERK1/2 by scaffolding complexes composed by ␤-arrestin, Src, and MAPK cascade effectors have already been reported (for review, see Lefkowitz and Shenoy, 2005) . The possibility that the G protein-independent, Src-dependent activation of ERK1/2 by 5-HT 4 Rs involves ␤-arrestin was analyzed. The first argument against this possibility was the transient time course of ERK1/2 activation by 5-HT 4 R, compared with the generally persistent ␤-arrestin-mediated activation of ERKs. The second counter-argument was that the C-terminal cluster of Ser/Thr, which was necessary for the recruitment of ␤-arrestin by the 5-HT 4 Rs and for their endocytosis after 15 min of stimulation (Barthet et al., 2005) , was not required for 5-HT 4 Rs-induced accumulation of p-ERKs (Figure 7) . We particularly studied the ⌬346 mutant that lacks this Ser/Thr cluster ( Figure 7A ) and showed that a 5-min agonist stimulation period of the truncated ⌬346 mutant induced a robust activation of ERK1/2 that was blocked by PP2 ( Figure 7A) . A larger truncation of the C-terminal domain ⌬327 did not modify the receptor's ability to mediate p-ERK1/2 accumulation, an effect blocked by PP2 (data not shown). We also confirmed that phosphorylation of ERKs by the ⌬346 mutant was associated with an increase in p-Src (Tyr 416) ( Figure  7B ), which colocalized with the receptor at the plasma membrane. However, a short 5-min stimulation provided a way for the native 5-HT 4 R WT to recruit ␤-arrestin 2-YFP and form complexes localized on the plasma membrane ( Figure  8A ). On the contrary, no complexes could be detected between ⌬346 and ␤-arrestin 2-YFP ( Figure 8A) . Thus, the ⌬346 mutant was unable to recruit ␤-arrestin, but at the same time, it was still able to activate p-ERK1/2 and p-Src accumulations ( Figure 7A ). These data exclude a role for ␤-arrestin in the 5-HT 4 R-mediated activation of ERKs.
We then analyzed by coimmunoprecipitation the physical interactions between p-Src and the receptors (WT and ⌬346) and between ␤-arrestins and the same receptors. Immunoprecipitation of Rho-tagged WT and ⌬346 -5-HT 4 Rs resulted in a significant basal coimmunoprecipitation of p-Src that
Immunofluorescence microscopy was performed using a Zeiss Axiophot2 microscope with Zeiss 63ϫ NA 1.4 oil immersion lenses. Representative images from several independent experiments are shown. Top, distribution of Rho-tagged 5-HT 4 R before (basal) or after 5-and 30-min addition of 10 M 5-HT to the culture medium at 37°C. The left column shows the distribution of the receptor and the absence of p-ERK1/2 before activation. An increase in phosphorylation state of ERK1/2 at the plasma membrane is visualized after 5-min treatment with 5-HT. Merged images were magnified to show colocalization of 5-HT 4 R with p-ERK1/2 at the plasma membrane after 5 min of stimulation. Bottom, phosphorylation state of p-Src (Tyr 416) before and after 5-HT 4 R stimulation. Phosphorylation state and colocalization with 5-HT 4 R is longer for p-Src than for p-ERK1/2. (C) HEK293 cells were transfected with 5-HT 4 R. Twentyfour hours later, the cells were starved in serum-free medium overnight and stimulated with 10 M 5-HT for the indicated periods at 37°C. Phosphorylated Src (Tyr 416) of all the cell lysates was determined by immunoblotting with the antibody to active p-Src (Tyr 416) and to total Src. was largely increased after a 5-min stimulation with 5-HT ( Figure 8B ). The amounts of p-Src coimmunoprecipitated were comparable between the WT and the ⌬346 ( Figure 8B , line 1). The presence of endogenous ␤-arrestins coimmunoprecipitated was solely observed after 5 min of stimulation of the WT-5-HT 4 R. These data confirm that ␤-arrestins were tightly associated with activated 5-HT 4 R WT. On the contrary, ⌬346 failed to interact with ␤-arrestin 1 and only weakly with ␤-arrestin 2 after stimulation ( Figure 8B , line 2). These huge differences in ␤-arrestin recruitment between WT and ⌬346 contrast with the equal aptitude of both WT and ⌬346 to recruit p-Src ( Figure 8B , line 1) and induce p-ERK1/2 activation ( Figure 7A ). Thus, Src and ERK1/2 activation did not seem to depend on physical interaction between 5-HT 4 Rs and ␤-arrestins.
Nonetheless, these results did not completely exclude the possibility that Src and ERK activations by 5-HT 4 Rs were dependent on ␤-arrestins. Thus, we examined the effect of ␤-arrestin depletion, by RNA interference, on 5-HT 4 R-mediated activation of p-ERK. As illustrated in Figure 8C , the depletion of both ␤-arrestins 1 and 2 ( Figure 8C , lines 3 and 4) does not affect the 5-HT 4 R-mediated Src and ERK1/2 activation ( Figure 8C , lines 1 and 2, respectively). The latter signal remains unaffected, whereas the amounts of ␤-arrestins 1 and 2 were reduced by Ͼ70%. Altogether, these data further confirm that ERK1/2 activation stimulated by 5-HT 4 R was not mediated by ␤-arrestin.
Moreover, neither ␤-arrestin nor receptor endocytosis were required. Overexpression of the dominant-negative ␤-arrestin (319 -418) (which blocked 5-HT 4 R endocytosis; Barthet et al., 2005) as well as inhibition of endocytosis with hypertonic 0.4 M sucrose or with concanavalin A had any effect on 5-HT 4 R-mediated ERK stimulation (data not shown). These observations support the immunofluores- transfected with 500 ng of Rho-tagged 5-HT 4 R or Rho-tagged ⌬346 were seeded onto coverslips. Twenty-four hours after transfection, cells were serum starved overnight. Cells were incubated 90 min with antibody against Rhotagged 5-HT 4 R at 4°C before a 5-or 30-min stimulation period with 10 M 5-HT. After fixation and permeabilization, the cells were sequentially incubated with primary antibody against p-ERK1/2 or p-Src (Tyr 416) and with fluorochrome-labeled secondary antibody. Fluorescence microscopy was then used to visualize distribution of antibody-labeled receptors (green channel) and appearance of the phosphorylated form of active ERK1/2 and active Src (red channel). Immunofluorescence microscopy was performed using a Zeiss Axiophot2 microscope with Zeiss 63ϫ NA 1.4 oil immersion lenses. Representative images from several independent experiments are shown. Top, distribution of Rho-tagged 5-HT 4 R or Rho-tagged ⌬346 before (basal) or after 5-min treatment with 10 M 5-HT at 37°C. An increase in phosphorylation of p-ERK1/2 is visualized at the plasma membrane after 5-min stimulation with 5-HT of both WT and ⌬346. Merged images were magnified to show colocalization of both receptors (WT and ⌬346) with p-ERK1/2 at the plasma membrane after stimulation. Bottom, phosphorylation state of active Src before (basal) and after (5 min) 5-HT 4 R stimulation. Phosphorylation states were enhanced after stimulation with 5-HT and localization of p-ERK and p-Src do not differ between WT and ⌬346 after 5-min stimulation.
cence studies indicating that p-ERK1/2 is present only at the plasma membrane level (Figures 6B and 7B) .
Stimulation of Endogenous 5-HT 4 Rs in Neurons Induces pERK1/2 Accumulation in a Src-dependent Manner
It was important to establish whether the activation of ERK1/2 by endogenous 5-HT 4 Rs also involves Src phosphorylation in a pure neuronal cell population. This was particularly interesting to analyze because a 5-to 200-fold higher level of this protein is expressed in brain, compared with other tissues, as reported by Thomas and Brugge (1997) . The data reported in Figure 9A revealed that in spite of a high basal content of p-Src (on Tyr 416), the 5-HT 4 R agonist BIMU8 increased p-Src (Tyr 416) content by 40 Ϯ 3%, as well as p-ERK1/2 accumulation by 76 Ϯ 5%. Moreover, pretreatment of neurons with 10 M PP2 markedly decreased phosphorylation of p-ERK1/2 ( Figure 9B ). These results further support the involvement of Src kinases in 5-HT 4 R-mediated ERK phosphorylation in neurons. Then, we examined a pathway often implicated in Src activation by a GPCR in neurons, the transactivation of EGF-R (Shah and Catt, 2004) . We tested the effect of AG1478, a selective EGF-R inhibitor, on ERK1/2 activation in response to 5-HT. As shown in Figure 9C , 250 nM AG1478 does not reduce ERK1/2 activation induced by 5-HT 4 R agonist in neurons, whereas it totally inhibits EGF-mediated stimulation. To study a possible role for G i , we treated neuronal cells with PTX ( Figure 9D ). This treatment had no effect on 5-HT 4 Rinduced ERK phosphorylation in neurons. These data clearly indicated that 5-HT 4 R expressed in HEK 293 cells or 5-HT 4 R endogenously expressed in colliculi neurons used the same pathway dependent on Src kinase to activate ERK phosphorylation.
DISCUSSION
The present study provides evidence that 5-HT 4 R stimulation, which mediates ERK activation, involves activation of the nonreceptor tyrosine kinase Src as a signaling event. If a number of GPCRs can function either independently of their G protein partners, or independently of ␤-arrestin, 5-HT 4 R mediated ERK activation is the first example that involves neither a classical G␣ protein signaling (G s /G q /G i ) and associated messengers, nor ␤-arrestins. ␤ 3 -AR does not require ␤-arrestins to induce ERK1/2 activation through a direct interaction with Src kinase, but it does require G i proteins (Cao et al., 2000) . V 2 vasopressin receptors act through a mechanism independently of G protein signaling, by involving Src and ␤-arrestin (Charest et al., 2007) .
In colliculi neurons, 5-HT 4 R-mediated ERK activation seems to be largely PKA independent, because BIMU8 still generated a strong ERK1/2 activation in the presence of 3 M CMIQ, a selective PKA inhibitor ( Figure 1D ). We Figure 8 . Arrestins are not implicated in Src-dependent 5-HT 4 Rmediated ERK1/2 activation. (A) ⌬346 does not promote ␤-arrestin 2 redistribution to the plasma membrane after stimulation. HEK293 transfected with 500 ng of Rho-tagged 5-HT 4 R or Rho-tagged ⌬346 were seeded onto coverslips. Twenty-four hours after transfection, cells were serum starved overnight. Cells were incubated 90 min with antibody against Rho-tagged 5-HT 4 R at 4°C before a 5-min stimulation with 10 M 5-HT. After fixation and permeabilization, cells were incubated with Alexa Fluor 594-labeled secondary antibody. Fluorescence microscopy was then used to visualize the distribution of antibody-labeled receptors (red channel) and the redistribution of YFP-␤-arrestin 2 (green channel). Immunofluorescence microscopy was performed using a Zeiss Axiophot2 microscope with Zeiss 63ϫ NA 1.4 oil immersion lenses. Representative images from several independent experiments are shown. Left, distribution of Rho-tagged WT and ␤-arrestin 2-YFP. WT-5-HT 4 R is expressed at the plasma membrane under basal conditions, whereas ␤-arrestin 2-YFP is homogenously present in the cytosol. After 5-min stimulation with 10 M 5-HT at 37°C, ␤-arrestin 2-YFP is redistributed to the plasma membrane where the stimulated 5-HT 4 Rs are localized. Merged images were magnified to show colocalization of wt 5-HT 4 R with ␤-arrestin 2-YFP at the plasma membrane. Right, distribution of Rho-tagged ⌬346 and ␤-arrestin 2-YFP. ⌬346, initially characterized to lack the ability to traffic in endosomes with ␤-arrestin 2 after a long-term stimulation, also lack the ability to promote the translocation of ␤-arrestin to the plasma membrane after a 5-min period of stimulation. (B) ⌬346 activates Src despite its inability to interact with ␤-arrestins. Cells transfected with Rho-tagged 5-HT 4 R WT or Rho-tagged ⌬346 (800 ng) were incubated with 10 M 5-HT for 5 min. 5-HT 4 Rs were purified from proteins extracts by immunoprecipitation by using anti-Rho-tag antibody. Coprecipitated proteins (p-Src and ␤-arrestins 1 and 2) were analyzed by Western blotting by using the antibody to p-Src (Tyr 416) (line 1) and the antibody to ␤-arrestins 1 and 2 (line 2). The presence of the receptor was revealed by using the antibody anti-Rho-tag (line 3). (C) Downregulation of ␤-arrestin expression by siRNA does not inhibit ERK phosphorylation mediated by 5-HT 4 R. Early passage HEK293 were transfected with 5-HT 4 R and with control or ␤-arrestin 1-and 2-specific siRNA. Seventy-two hours after transfection, cells were stimulated 5 or 30 min before lysis. p-Src, p-ERK, and ␤-arrestin contents were analyzed by Western blotting. The same blot was probed and stripped, sequentially, for p-Src (Tyr 416) and p-ERK1/2 (lines 1 and 2) and ␤-arrestins (lines 3 and 4). A representative illustration of three experiments is shown in A-C.
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Vol. 18, June 2007checked that 3 M CMIQ was a concentration high enough to fully inhibit PKA in neurons ( Figures 1C and 4C) . Similarly, in HEK293 cells, inhibiting PKA either with 3 M CMIQ or 1 M H-89 did not result in inhibition of 5-HT 4 Rinduced stimulation of ERK in these cells ( Figure 4C ). These results were unexpected, because in a previous report on HEK293 cells transfected with 5-HT 4 Rs, 20 M H-89 inhibited 5-HT-induced ERK1/2 activation (Norum et al., 2003) . The reasons for this discrepancy are not known. One possible explanation could be that at 20 M H-89 loses its specificity and inhibits other kinases in addition to PKA. Indeed, a previous report mentions that from 10 M, H-89 inhibited many kinases even stronger than PKA (Davies et al., 2000) .
Based on these observations, we can postulate that the G s /cAMP/PKA pathway and activation of ERK1/2 could be two independent 5-HT 4 R-mediated signaling both in neurons and HEK293 cells. It is interesting to note that Dyer et al. (2003) demonstrated that 5-HT-mediated ERK activation in Aplysia sensory neurons was not dependent on cAMP. These data do not indicate that cAMP is not able to stimulate ERK activation in neurons but only that activation of ERK by 5-HT 4 Rs is mostly cAMP/PKA independent. Indeed, activation of ERKs via a cAMP route is known to occur in several cells, such as primary neurons in culture (Vincent et al., 1998) , PC12 cells, melanocytes, and thyroid cells, and it generally occurs via a B-Raf-MEK pathway (Dumaz and Marais, 2005) . In contrast, in many other cells, cAMP inhibits ERK via inhibition of C-Raf, which leads to the well-known antiproliferate effects of cAMP (Dumaz and Marais, 2005) .
We have used several pharmacological and genetic tools to obtain further arguments to exclude the G s /cAMP/PKA pathway in HEK293 cells. SQ 22536, a potent inhibitor of the adenylyl cyclase, suppresses 5-HT 4 R-induced cAMP production without suppressing 5-HT 4 R-induced ERK activation. Finally, the D66N receptor mutants that stimulate cAMP production are unable to activate the ERK1/2 pathway. We also exclude any implication of the G q /PLC pathway. For unknown reasons, 5-HT 4 Rs activate the production of IP in HEK293 cells but not in neurons (our unpublished data). Thus, we looked for a possible role of the G q /PLC pathway in 5-HT 4 R-induced ERK activation in HEK293 cells. The role of PLC activation was excluded by showing that U 73122, an inhibitor of PLC, but not its inactive analogue, does not suppress the effect of 5-HT 4 Rs on p-ERK1/2, whereas it decreases their ability to activate IP production ϳ75%. In addition, the W272A (W 6.48 ) receptor mutants do not activate IP production, but they stimulate ERK activation. Finally, we eliminated a contribution of G i by pretreating cells with PTX. Indeed, a switch from G s to G i can occur for G s -coupled receptors, as demonstrated for ␤ 2 -AR. In this latter case, the switch to G i after G s activation allows a subsequent stimulation of G i , and the release of ␤␥ subunits that causes ERK activation (Daaka et al., 1997) . Our data also eliminate the PI3K pathway and transactivation of EGF receptor tyrosine kinases as contributors to 5-HT 4 R-mediated ERK activation. It was surprising to find that classical G protein signaling pathways are not implicated in 5-HT 4 R-mediated ERK activation. Indeed, the rapid and transient time course of this activation was similar to the G protein-dependent components of ERK activation by other GPCRs, such as AT1AR, V 2 R and also ␤ 2 -AR (Shenoy et al., 2006) . The classical paradigm that relates the strong but transient increase of the p-ERK1/2 signal to the G protein-dependent pathway (Lefkowitz and Shenoy, 2005) seems to present some exceptions.
Indeed, 5-HT 4 R stimulation of p-ERK is totally dependent of Src activation. Moreover, the concentration-response curve of the 5-HT 4 R ligand-mediated p-ERK indicated that only high concentrations of agonist contributed to p-ERK phosphorylation (Ͼ10 Ϫ7 M). No p-ERK signal was observed before administering 10 Ϫ7 M 5-HT 4 R agonist, whereas cAMP formation was maximal at 10 Ϫ8 M 5-HT. Our observations are consistent with those by Sun et al. (2007) who recently reported that ␤ 2 -AR G protein-coupled signaling needs low concentrations of isoproterenol, whereas ␤ 2 -AR non-G protein signaling needs high concentrations of this agonist (Sun et al., 2007) . Why do G s protein/cAMP-and Src-dependent signaling pathways require such different agonist concentrations when they involve the same 5-HT 4 R? One likely explanation is that the receptor can adopt two different activated (R*) conformations. One conformation is stabilized by low 5-HT concentrations (activating the G s signaling pathway), and the other conformation is stabilized by high 5-HT concentrations (activating the Src signaling pathway). In this regard, we have already provided evidence for the occurrence of multiple and well-defined conformational states of the 5-HT 4 R, depending on the ligand (Baneres et al., 2005) .
Previous observations demonstrate that activation of 5-HT 4 Rs in the enterocyte cell line Caco2 inhibits apical Cl Ϫ /OH Ϫ exchange activity, via activation of the nonreceptor tyrosine kinase Src (Saksena et al., 2005) . This result does not seem to be cell specific, because we demonstrated that 5-HT 4 Rs also stimulated Src activation, both in epithelial HEK293 cell lines and in neurons in primary culture. In these cells, activation of Src was required to activate the ERK1/2 pathway by 5-HT 4 Rs.
By immunoblotting and immunofluorescence staining, we observed that the ERK1/2 activation by 5-HT 4 Rs was very transient. In contrast, the activation of Src was more persistent and still present at 30 min. Active Src remained associated with the internalized receptor and was accumulated in a perinuclear compartment. Moreover, upon stimulation, 5-HT 4 Rs coimmunoprecipitated with p-Src. Further work is needed to determine the putative cellular role, if any, of this endocytosed receptor-p-Src complex.
One of the key questions was to know how 5-HT 4 Rs mediate Src activation. Do 5-HT 4 Rs recruit Src kinase directly, or do they require ␤-arrestin recruitment, as shown for some GPCRs (Lefkowitz and Shenoy, 2005) ? We used many approaches to demonstrate that ␤-arrestin recruitment was not necessary to observe a 5-HT 4 R-mediated phosphorylation of both ERK and Src. First, the time course of 5-HTinduced ERK activation ( Figures 1B and 2A) did not support the involvement of ␤-arrestin in the 5-HT 4 R-induced p-ERK1/2 accumulation. Indeed, the ␤-arrestin-dependent activation of ERK1/2 by GPCRs was associated with receptor endocytosis and was generally slow and persistent (Shenoy et al., 2006) , whereas the 5-HT 4 R activation of ERK1/2 was very rapid and transient. Second, the absence of involvement of ␤-arrestin in this pathway was also supported by our previous and present reports demonstrating that the ⌬346 mutant, devoid of the C-terminal tail cluster of serine/threonine, failed to bind to ␤-arrestin, but it was able to stimulate ERK1/2 in a Src-dependent manner, like native 5-HT 4 Rs. Third, the depletion by RNA interference of ␤-arrestins 1 and 2 did not modify the ability of 5-HT 4 Rs to induce ERK1/2 and Src phosphorylations. All these data clearly confirm that ERK activation stimulated by 5-HT 4 R was not mediated by ␤-arrestin. This was an unexpected finding, because 5-HT 4 Rs belong to class B type, and they have been shown to be stably associated with ␤-arrestin without recycling or degradation over a long period (Barthet et al., 2005) .
Arrestin seems to be an absolute requirement for ERK activation by some GPCRs, including ␣ 2 -ARs (Wang et al., 2004) , gonadotropin-releasing hormone receptors (Benard et al., 2001) , and the D2 and D3 dopamine receptors (Beom et al., 2004) . However, 5-HT 4 Rs seem to be the only GPCRs that activate ERK1/2 in a G protein signaling-independent and ␤-arrestin-independent pathway. Note also that 5-HT 4 Rmediated ERK1/2 activation was also independent of receptor endocytosis, as already demonstrated for the ␣ 2 -AR (Wang et al., 2004) . To date, we have not been able to determine whether Src and p-Src interact directly or indirectly via other unknown scaffolding proteins to 5-HT 4 Rs. The absence of a PXXP sequence in 5-HT 4 R sequences excludes the possibility that the receptors bind to the Src homology 3 (SH3) domain. In contrast, there are several Tyr residues within the cytoplasmic domains of the 5-HT 4 Rs (loops i 2 , i 3 ) and carboxy terminal (C-t) that are all putative SH2-binding sites after phosphorylation. The different C-t truncated 5-HT 4 Rs (⌬327 and ⌬346) were still able to activate the ERK cascade through Src. This indicates that the Tyr residues of C-t were not implicated in Src recruitment. This is in contrast with what has been reported for the ␤ 2 -AR. Indeed, Fan et al. (2001) demonstrated that phospho-Tyr 350 in the C-t of ␤ 2 -AR is important for Src binding. However, in contrast to our data, Src binds the ␤ 2 -AR to mediate agonistinduced receptor desensitization but not to mediate ERK activation (Fan et al., 2001) . We have generated several mutants in which, Tyr was substituted by Phe (Tyr 119, Tyr 129, Tyr 212, and Tyr 216) present in i 2 and i 3 loops. Unfortunately, all the mutants could still recruit p-Src and stimulate ERK1/2, in a pathway sensitive to PP2 (data not shown). Therefore, it is possible that either an intermediary protein is necessary for the 5-HT 4 R-pSrc association or that a conformational epitope of the receptor is needed for p-Src recruitment.
The ERK1/2 signaling pathway is critical for multiple cellular processes that include proliferation, differentiation, survival, and migration. Kinetics and subcellular compartmentalization of p-ERKs are the major factors determining which cellular responses are triggered by active ERK signaling (Caunt et al., 2006) . In our study, we clearly observed a plasma membrane-restricted ERK activation by immunofluorescence ( Figures 6B and 7B) . These data are similar to previous findings by Scott et al. (2006) demonstrating a role of activated ERK1/2 at the plasma membrane. In this compartment, p-ERK seems to be implicated in membrane ruffling and cell migration in Hep2 epithelial cells. In neurons, ERK activated at the plasma membrane level could participate in morphological modifications involved in neuroplasticity: neurite outgrowth, dendritic spine maturation, or synapse formation. The finding that 5-HT 4 Rs activate ERK in neurons sheds light on the capacity of 5-HT 4 R agonists to improve recognition memory, spatial learning, and cognition (Marchetti et al., 2000 (Marchetti et al., , 2004 Micale et al., 2006) . Moreover, this signaling pathway could participate in a 5-HT 4 R-generated shift from long-term depression to LTP in the hippocampal CA1 region, a process that supports memory formation Manahan-Vaughan, 2004, 2005) .
Our data highlight an emerging role for 5-HT 4 Rs in mediating ERK activation that could be important in learning and memory. We propose that the link between 5-HT 4 Rs and memory could involve both the cAMP/PKA and the Src/ERK signaling pathways. Nonetheless, a direct relationship between 5-HT 4 R-mediated ERK activation and memory processing requires further investigation.
